Statin Therapy Does Not Affect the Radiographic and Clinical Profile of Patients with TIA and Minor Stroke

References

1. 1.↵
   2. Amarenco P,
   3. Bogousslavsky J,
   4. Callahan A 3rd., et al

   . High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006;355:549–59

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Amin-Hanjani S,
   3. Stagliano NE,
   4. Yamada M, et al

   . Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice. Stroke 2001;32:980–86

   Abstract/FREE Full Text
3. 3.↵
   2. Kawashima S,
   3. Yamashita T,
   4. Miwa Y, et al

   . HMG-CoA reductase inhibitor has protective effects against stroke events in stroke-prone spontaneously hypertensive rats. Stroke 2003;34:157–63

   Abstract/FREE Full Text
4. 4.↵
   2. Endres M,
   3. Laufs U,
   4. Huang Z, et al

   . Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci U S A 1998;95:8880–85

   Abstract/FREE Full Text
5. 5.↵
   2. Blanco M,
   3. Nombela F,
   4. Castellanos M, et al

   . Statin treatment withdrawal in ischemic stroke: a controlled randomized study. Neurology 2007;69:904–10

   CrossRef
6. 6.↵
   2. Montaner J,
   3. Chacon P,
   4. Krupinski J, et al

   . Simvastatin in the acute phase of ischemic stroke: a safety and efficacy pilot trial. Eur J Neurol 2008;15:82–90

   PubMed
7. 7.↵
   2. Elkind MS,
   3. Flint AC,
   4. Sciacca RR, et al

   . Lipid-lowering agent use at ischemic stroke onset is associated with decreased mortality. Neurology 2005;65:253–58

   CrossRef
8. 8.↵
   2. Sacco S,
   3. Toni D,
   4. Bignamini AA, et al

   . Effect of prior medical treatments on ischemic stroke severity and outcome. Funct Neurol 2011;26:133–39

   PubMed
9. 9.↵
   2. Moonis M,
   3. Kane K,
   4. Schwiderski U, et al

   . HMG-CoA reductase inhibitors improve acute ischemic stroke outcome. Stroke 2005;36:1298–300

   Abstract/FREE Full Text
10. 10.↵
    2. Ní Chróinín D,
    3. Asplund K,
    4. Asberg S, et al

    . Statin therapy and outcome after ischemic stroke: systematic review and meta-analysis of observational studies and randomized trials. Stroke 2013;44:448–56

    Abstract/FREE Full Text
11. 11.↵
    2. Pikija S,
    3. Cvetko D,
    4. Malojcic B, et al

    . A population-based prospective 24-month study of stroke: incidence and 30-day case-fatality rates of first-ever strokes in Croatia. Neuroepidemiology 2012;38:164–71

    CrossRefPubMed
12. 12.↵
    2. Johnston SC,
    3. Gress DR,
    4. Browner WS, et al

    . Short-term prognosis after emergency department diagnosis of TIA. JAMA 2000;284:2901–06

    CrossRefPubMedWeb of Science
13. 13.↵
    2. Hill MD,
    3. Yiannakoulias N,
    4. Jeerakathil T, et al

    . The high risk of stroke immediately after transient ischemic attack: a population-based study. Neurology 2004;62:2015–20

    CrossRef
14. 14.↵
    2. Coutts SB,
    3. Hill MD,
    4. Campos CR, et al

    . Recurrent events in transient ischemic attack and minor stroke: what events are happening and to which patients? Stroke 2008;39:2461–66

    Abstract/FREE Full Text
15. 15.↵
    2. Kennedy J,
    3. Hill MD,
    4. Ryckborst KJ, et al

    . Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol 2007;6:961–69

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Merwick A,
    3. Albers GW,
    4. Arsava EM, et al

    . Reduction in early stroke risk in carotid stenosis with transient ischemic attack associated with statin treatment. Stroke 2013;44:2814–20

    Abstract/FREE Full Text
17. 17.↵
    2. Coutts SB,
    3. Modi J,
    4. Patel SK, et al

    . CT/CT angiography and MRI findings predict recurrent stroke after transient ischemic attack and minor stroke: results of the prospective CATCH study. Stroke 2012;43:1013–17

    Abstract/FREE Full Text
18. 18.↵
    2. Lindsay P,
    3. Bayley M,
    4. McDonald A, et al

    . Toward a more effective approach to stroke: Canadian Best Practice Recommendations for Stroke Care. CMAJ 2008;178:1418–25

    Abstract/FREE Full Text
19. 19.↵
    2. Asdaghi N,
    3. Hill MD,
    4. Coulter JI, et al

    . Perfusion MR predicts outcome in high-risk transient ischemic attack/minor stroke: a derivation-validation study. Stroke 2013;44:2486–92

    Abstract/FREE Full Text
20. 20.↵
    2. Kosior JC,
    3. Idris S,
    4. Dowlatshahi D, et al

    . Quantomo: validation of a computer-assisted methodology for the volumetric analysis of intracerebral haemorrhage. Int J Stroke 2011;6:302–05

    CrossRefPubMed
21. 21.↵
    2. Coutts SB,
    3. Modi J,
    4. Patel SK, et al

    . What causes disability after transient ischemic attack and minor stroke? Results from the CT And MRI in the Triage of TIA and Minor Cerebrovascular Events to Identify High Risk Patients (CATCH) Study. Stroke 2012;43:3018–22

    Abstract/FREE Full Text
22. 22.↵
    2. Horton M,
    3. Modi J,
    4. Patel SK, et al

    . Refinement of imaging predictors of recurrent events following transient ischemic attack and minor stroke. PLoS One 2013;8:e65752

    CrossRefPubMed
23. 23.↵
    2. Lavallée PC,
    3. Meseguer E,
    4. Abboud H, et al

    . A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurol 2007;6:953–60

    CrossRefPubMedWeb of Science
24. 24.↵
    2. Rothwell PM,
    3. Giles MF,
    4. Chandratheva A, et al

    . Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet 2007;370:1432–42

    CrossRefPubMedWeb of Science
25. 25.↵
    2. Engelhorn T,
    3. Doerfler A,
    4. Heusch G, et al

    . Reduction of cerebral infarct size by the AT1-receptor blocker candesartan, the HMG-CoA reductase inhibitor rosuvastatin and their combination: an experimental study in rats. Neurosci Lett 2006;406:92–96

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Saito T,
    3. Nito C,
    4. Ueda M, et al

    . Continuous oral administration of atorvastatin ameliorates brain damage after transient focal ischemia in rats. Life Sci 2014;94:106–14

    CrossRefPubMed
27. 27.↵
    2. Cui L,
    3. Zhang X,
    4. Yang R, et al

    . Neuroprotection of early and short-time applying atorvastatin in the acute phase of cerebral ischemia: down-regulated 12/15-LOX, p38MAPK and cPLA2 expression, ameliorated BBB permeability. Brain Res 2010;1325:164–73

    CrossRefPubMed
28. 28.↵
    2. Laufs U

    . Beyond lipid-lowering: effects of statins on endothelial nitric oxide. Eur J Clin Pharmacol 2003;58:719–31

    PubMedWeb of Science
29. 29.↵
    2. Vaughan CJ,
    3. Murphy MB,
    4. Buckley BM

    . Statins do more than just lower cholesterol. Lancet 1996;348:1079–82

    CrossRefPubMedWeb of Science
30. 30.↵
    2. Kinlay S,
    3. Schwartz GG,
    4. Olsson AG, et al

    . Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study. Circulation 2004;110:386–91

    Abstract/FREE Full Text
31. 31.↵
    2. Ray KK,
    3. Cannon CP,
    4. McCabe CH, et al

    . Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial. J Am Coll Cardiol 2005;46:1405–10

    CrossRefPubMedWeb of Science
32. 32.↵
    2. Nicholas JS,
    3. Swearingen CJ,
    4. Thomas JC, et al

    . The effect of statin pretreatment on infarct volume in ischemic stroke. Neuroepidemiology 2008;31:48–56

    CrossRefPubMed
33. 33.↵
    2. Shook SJ,
    3. Gupta R,
    4. Vora NA, et al

    . Statin use is independently associated with smaller infarct volume in nonlacunar MCA territory stroke. J Neuroimaging 2006;16:341–46

    CrossRefPubMedWeb of Science
34. 34.↵
    2. Deplanque D,
    3. Masse I,
    4. Lefebvre C, et al

    . Prior TIA, lipid-lowering drug use, and physical activity decrease ischemic stroke severity. Neurology 2006;67:1403–10

    CrossRef
35. 35.↵
    2. Martí-Fàbregas J,
    3. Gomis M,
    4. Arboix A, et al

    . Favorable outcome of ischemic stroke in patients pretreated with statins. Stroke 2004;35:1117–21

    Abstract/FREE Full Text
36. 36.↵
    2. Jonsson N,
    3. Asplund K

    . Does pretreatment with statins improve clinical outcome after stroke? A pilot case-referent study. Stroke 2001;32:1112–15

    Abstract/FREE Full Text